NBTX Nanobiotix
WatchlistNanobiotix News
Johnson & Johnson Discloses Stake in Nanobiotix
Johnson & Johnson (JNJ) unit Johnson & Johnson Innovation-JJDC late Thursday disclosed a 10% stake in Nanobiotix (NBTX). The acquired stake amounts to 4.72 million American depositary shares of the Pa
NANOBIOTIX Q3 Cash And Cash Equivalents €38.7M As Of Sept. 30, 2023
NANOBIOTIX Q3 Cash And Cash Equivalents €38.7M As Of Sept. 30, 2023
Nanobiotix Reports Q3 Results
NANOBIOTIX to Announce Third Quarter 2023 Operational and Financial Update on November 13, 2023
PARIS and CAMBRIDGE, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients
Nanobiotix Raises EUR50.9 Million via Global Follow-on Offering
Nanobiotix (NANO.PA) raised 50.9 million euros upon completion of its global follow-on offering to specified categories of investors in the US and France, according to a late Tuesday release. The tota
NANOBIOTIX Announces Closing of Global Offering
PARIS and CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – "Nanobiotix" or the "Company"), a late-clinical stage biotechnology company pioneering physi
Nanobiotix Prices $55 Million Share Sale in US, Europe; Paris Stock Closes Lower
Nanobiotix (NANO.PA) on Thursday priced its US and European share offerings to raise $55 million to primarily help fund a late-stage and other costs for its treatment candidate for locally advanced he
Why Nanobiotix (NBTX) Stock Is Plunging Thursday
Nanobiotix SA - ADR (NASDAQ:NBTX) shares are trading lower by 16.4% to $5.14 Thursday morning after the company priced its global follow-on offering. The offering includes 3,106,907 ADSs in the U.S. a
NANOBIOTIX Announces Pricing of a Capital Increase Raising Total Gross Proceeds of $55M
PARIS and CAMBRIDGE, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – "Nanobiotix" or the "Company"), a late-clinical stage biotechnology company pioneering physics-based approaches
Nanobiotix Seeks $30 Million From Global Share Sale
Nanobiotix (NANO.PA) on Wednesday said it will launch a $30 million follow-on offering to US and European investors of its American depositary and ordinary shares. Under the offering, Johnson & Johnso
NANOBIOTIX Announces Launch of Global Follow-On Offering and a Concurrent Private Placement Along With the Removal of the EIB Cash Covenant
PARIS and CAMBRIDGE, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – "Nanobiotix" or the "Company"), a late-clinical stage biotechnology company pioneering physi
Nanobiotix Says Pancreatic, Head, Neck Cancers Phase 1 Studies of NBTXR3 Show Higher Median Overall Survival
Nanobiotix (NBTX) said Monday that a phase 1 study evaluating chemotherapy followed by radiotherapy-activated NBTXR3 in patients with locally advanced pancreatic cancer showed a median overall surviva
NANOBIOTIX Announces Updated Preliminary Results From Phase 1 Pancreatic Cancer Trial And New Exploratory Analysis From Completed Phase 1 Head And Neck Cancer Trial
Strategic Collaborator-presented Phase 1 Pancreatic Cancer DataAn ongoing Phase 1, collaborator-led study of NBTXR3 in locally advanced pancreatic cancer (LAPC) established a favorable safety profile
NANOBIOTIX Announces Updated Preliminary Results From Phase 1 Pancreatic Cancer Trial and New Exploratory Analysis From Completed Phase 1 Head and Neck Cancer Trial at ESMO 2023
NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the "Company"), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersRVL Pharmaceuticals (NASDAQ:RVLP) shares rose 19.5% to $0.13 during Friday's pre-market session. The company's market cap stands at $14.6 million. Vaccinex (NASDAQ:VCNX) shares moved upwards by
Top Premarket Decliners
OmniQ (OMQS) shares slumped 42% Friday premarket after the company priced a $3 million public offering of common stock and pre-funded warrants. China Natural Resources (CHNR) shares tumbled 30%, rever
Biggest Stock Movers Today: Pioneer Natural Resources, Aehr Test Systems and More
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersOrchard Therapeutics (NASDAQ:ORTX) shares increased by 96.5% to $15.99 during Thursday's regular session. As of 13:31 EST, Orchard Therapeutics's stock is trading at a volume of 7.9 million, wh
Express News | Nanobiotix Shares Are Trading Lower. The Company Late Wednesday Announced the Presentation of a Final Efficacy Analysis From the Phase 1 Cohort Expansion Evaluating NBTXR3 in Locally Advanced Head and Neck Cancer
Dow Falls 50 Points; Weekly Jobless Claims Edge Higher
U.S. stocks traded lower this morning, following the release of economic reports. Following the market opening Thursday, the Dow traded down 0.15% to 33,078.88 while the NASDAQ fell 0.28% to 13,199.32